Full Event Guide
Download the 2024 Full Event Guide to Discover:
- Data-driven case studies diving into clinical data and next-gen LNPs with Moderna, and Cytodigm
- Over 50% talks sharing novel data, including Moderna, Azane Therapeutics, and Sanofi
- Exclusive talks to overcome your toughest challenges: in vitro tools, PEG immunogenicity, ionizable lipids, immune reactivity, non-clinical testing strategy and safe delivery.
- Discover 3-deep dive workshops, expertly led by Pfizer, Eli Lilly, and Korro Bio on immune characterization, toxicity of LNP components and regulatory guidelines
Having trouble downloading the brochure? Let us know and we'll email it to you instead.
Speaker Testimonials
Liping Zhou,
Senior Director - Advanced Drug Delivery AstraZeneca
"There are quite some progress in non-viral delivery of nucleic acids in recent years. However, to make such a delivery platform suitable and safe to more applications require better understanding of the mechanism and minimization of unwanted side effects. I am looking forward to hearing new progress in this aspect and sharing experience from scientists of different organizations".
"This is a unique opportunity for industry leaders to come together and discuss the challenges and opportunities facing the LNP-based development programs".
Mohammad Shadid,
Vice President - Translational Sciences Preclinical Development, Korro Bio
Companies On the Program Include:
